| Long name: |
OPRM1 (Ab-375) Polyclonal Antibody |
| Antigen: |
OPRM1 |
| Synonim names: |
LMOR, M-OR-1, MOR, MOR1, OPRM, MOP |
| Other names: |
N/A, partial, OPRM1 |
| Gene name: |
OPRM1, OPRM1 |
| Category: |
Antibodies |
| Clonality: |
Polyclonal Antibodies |
| Clone: |
Not applicable to Polyclonal Antibodies |
| Reacts with: |
Mouse (Mus musculus), Rat (Rattus norvegicus), Human (Homo sapiens) |
| Specificity: |
OPRM1, This is an antibody designed to detect OPRM1 |
| Purification method: |
This antibody was purified via antigen affinity purification method |
| Concentration: |
1mg/mL |
| Storage, shipping and handling: |
Avoid cycles of freezing and thawing as they may denaturate the polypeptide chains of the antibody, Due to transportation or handling reasons, For longer periods of time we recommend keeping the vial frozen at -40 or -80, Upon receving, We recommend you to briefly cetrifuge the vial prior to use to gather the content on the bottom, freeze at -20, small amounts of the antibody might get caught on the lid or walls of the vial, The antibody is shipped at +4 degrees Celsius |
| Applications: |
Western Blot (WB) |
| Properties: |
C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by MBS Polyclonals they should be stored frozen at - 24° |
| Gene target: |
OPRM1 |
| Short name: |
Anti- OPRM1 Antibody |
| Technique: |
antibodies against human proteins, antibodies for, Antibody |
| Alternative name: |
mu 1 (Antibody to), Antibody to opioid receptor |
| Alternative technique: |
antibodies |
| Alternative to gene target: |
Cell surfaces, LMOR and M-OR-1 and MOP and MOR and MOR1 and OPRM, OPRM1 and IDBG-635007 and ENSBTAG00000019719 and 281958, OPRM1 and IDBG-98194 and ENSG00000112038 and 4988, Oprm1 and IDBG-130147 and ENSMUSG00000000766 and 18390, coupled to cyclic nucleotide second messenger and biological process this GO :0007191 and adenylate cyclase-activating dopamine receptor signaling pathway and biological process this GO :0007193 and adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway and biological process this GO :0007194 and negative regulation of adenylate cyclase activity and biological process this GO :0007200 and phospholipase C-activating G-protein coupled receptor signaling pathway and biological process this GO :0007204 and positive regulation of cytosolic calcium ion concentration and biological process this GO :0007218 and neuropeptide signaling pathway and biological process this GO :0007600 and sensory perception and biological process this GO :0007626 and locomotory behavior and biological process this GO :0008285 and negative regulation of cell proliferation and biological process this GO :0016020 and membrane and cellular component this GO :0016021 and integral component of membrane and cellular component this GO :0019233 and sensory perception of pain and biological process this GO :0019904 and protein domain specific binding and molecular function this GO :0030425 and dendrite and cellular component this GO :0031005 and filamin binding and molecular function this GO :0031635 and adenylate cyclase-inhibiting opioid receptor signaling pathway and biological process this GO :0031681 and G-protein beta-subunit binding and molecular function this GO :0032094 and response to food and biological process this GO :0032100 and positive regulation of appetite and biological process this GO :0032496 and response to lipopolysaccharide and biological process this GO :0032590 and dendrite membrane and cellular component this GO :0032839 and dendrite cytoplasm and cellular component this GO :0033554 and cellular response to stress and biological process this GO :0038003 and opioid receptor signaling pathway and biological process this GO :0038047 and morphine receptor activity and molecular function this GO :0042060 and wound healing and biological process this GO :0042220 and response to cocaine and biological process this GO :0042383 and sarcolemma and cellular component this GO :0043204 and perikaryon and cellular component this GO :0043278 and response to morphine and biological process this GO :0043950 and positive regulation of cAMP-mediated signaling and biological process this GO :0043951 and negative regulation of cAMP-mediated signaling and biological process this GO :0045019 and negative regulation of nitric oxide biosynthetic process and biological process this GO :0045121 and membrane raft and cellular component this GO :0045429 and positive regulation of nitric oxide biosynthetic process and biological process this GO :0048149 and behavioral response to ethanol and biological process this GO :0050769 and positive regulation of neurogenesis and biological process this GO :0051481 and negative regulation of cytosolic calcium ion concentration and biological process this GO :0051930 and regulation of sensory perception of pain and biological process this GO :0060079 and regulation of excitatory postsynaptic membrane potential and biological process this GO :0061358 and negative regulation of Wnt protein secretion and biological process this GO :0070374 and positive regulation of ERK1 and ERK2 cascade and biological process this GO :0070588 and calcium ion transmembrane transport and biological process this GO :0070848 and response to growth factor and biological process this GO :0071315 and cellular response to morphine and biological process this GO :2000310 and regulation of N-methyl-D-aspartate selective glutamate receptor activity and biological process, morphine receptor activity, mu 1, this GO :0001965 and G-protein alpha-subunit binding and molecular function this GO :0002438 and acute inflammatory response to antigenic stimulus and biological process this GO :0004930 and G-protein coupled receptor activity and molecular function this GO :0004979 and beta-endorphin receptor activity and molecular function this GO :0004985 and opioid receptor activity and molecular function this GO :0005245 and voltage-gated calcium channel activity and molecular function this GO :0005515 and protein binding and molecular function this GO :0005737 and cytoplasm and cellular component this GO :0005783 and endoplasmic reticulum and cellular component this GO :0005794 and this GO lgi apparatus and cellular component this GO :0005886 and plasma membrane and cellular component this GO :0005887 and integral component of plasma membrane and cellular component this GO :0005925 and focal adhesion and cellular component this GO :0007186 and G-protein coupled receptor signaling pathway and biological process this GO :0007187 and G-protein coupled receptor signaling pathway, this GO :0001965 : G-protein alpha-subunit binding, this GO :0001965 : G-protein alpha-subunit binding and also this GO :0004930 : G-protein coupled receptor activity and also this GO :0004979 : beta-endorphin receptor activity and also this GO :0004985 : opioid receptor activity and also this GO :0005245 : voltage-gated calcium channel activity and also this GO :0005515 : protein binding and also this GO :0019904 : protein domain specific binding and also this GO :0031005 : filamin binding and also this GO :0031681 : G-protein beta-subunit binding and also this GO :0038047 : morphine receptor activity, this GO :0004930 : G-protein coupled receptor activity, this GO :0004979 : beta-endorphin receptor activity, this GO :0004985 : opioid receptor activity, this GO :0005245 : voltage-gated calcium channel activity, this GO :0005515 : protein binding, this GO :0019904 : protein domain specific binding, this GO :0031005 : filamin binding, this GO :0031681 : G-protein beta-subunit binding, this GO :0038047 : morphine receptor activity, opioid receptor |
| Identity: |
8156 |
| Gene: |
OPRM1 |
More about : OPRM1 |
| Long gene name: |
opioid receptor mu 1 |
| Synonyms gene name: |
mu 1 , opioid receptor |
| Synonyms: |
MOR1 |
| Locus: |
6q25, 2 |
| Discovery year: |
1993-03-11 |
| GenBank acession: |
L29301 |
| Entrez gene record: |
4988 |
| RefSeq identity: |
NM_000914 |
| Classification: |
Opioid receptors |
| Havana BLAST/BLAT: |
OTTHUMG00000015870 |
| Locus Specific Databases: |
LRG_1007 |